Updated 16/06/2019
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 24,338
High 6.100
Low 5.200
Open 5.200
ISIN ES0109659013
Prev close 5.600
# of shares -
Market cap -

Market closed
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  5.60 12.0% Stock price increasing 29.6% Stock price increasing 31.5% Stock price increasing 79.5% Stock price increasing 47.4% Stock price increasing
Powered by TradingView

Company profile

AB Biotics is a biotechnology company engaged in the research and development of probiotics and specialty dietary supplements. It manufactures drugs for cardiometabolic, oral care pediatrics, gastrointestinal, gynecology and urology, dermatology and immunology areas. The company also offers a wide range of genomic services including genetic tests in the fertility and pain treatment fields. Its product offerings include AB-Immuno, AB-sakei 65, AB-Kolicare, AB- Cyscare, AB- Dentalac Pro, AB- Dentalac Junior, among others.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
18 June 2019 04:55:13
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB5 - 2019-06-18 05:55:13 - 2019-06-18 04:55:13 - 1000 - Website: OKAY